Peter Buggisch Selected Research

ferroglycine sulfate

1/2005

Bioavailability of oral iron drugs as judged by a 59Fe-whole-body counting technique in patients with iron deficiency anaemia. Therapeutic efficacy of iron(II)-glycine sulfate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Buggisch Research Topics

Disease

44	Infections 01/2022 - 01/2006
26	Chronic Hepatitis C 01/2022 - 06/2003
21	Hepatitis C 01/2022 - 02/2006
20	Fibrosis (Cirrhosis) 07/2022 - 05/2008
7	Liver Diseases (Liver Disease) 01/2022 - 01/2006
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 09/2008
6	Chronic Hepatitis B 10/2019 - 09/2006
5	Viremia 03/2013 - 04/2006
4	Virus Diseases (Viral Diseases) 01/2021 - 01/2018
3	HIV Infections (HIV Infection) 07/2022 - 01/2006
2	Alcoholism (Alcohol Abuse) 01/2021 - 05/2008
2	Mental Disorders (Mental Disorder) 01/2021 - 07/2012
2	Hepatocellular Carcinoma (Hepatoma) 09/2020 - 01/2013
2	Disease Progression 12/2019 - 01/2013
2	Pruritus (Itching) 10/2017 - 02/2012
2	Coinfection 05/2008 - 11/2006
2	Acquired Immunodeficiency Syndrome (AIDS) 05/2008 - 11/2006
2	Persistent Infection 09/2006 - 02/2006
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Depressive Disorder (Melancholia) 01/2021
1	Weight Loss (Weight Reduction) 12/2020
1	Hepatitis B 12/2019
1	Chronic Renal Insufficiency 11/2019
1	Peptic Ulcer (Peptic Ulcers) 01/2019
1	Gastroesophageal Reflux (GERD) 01/2019
1	Spasm (Spasms) 10/2017
1	Dizziness (Lightheadedness) 10/2017
1	Nausea 10/2017
1	Myalgia 10/2017
1	Dyspepsia (Indigestion) 10/2017
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2017
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 03/2016
1	Neutropenia 01/2013

Drug/Important Bio-Agent (IBA)

30	Antiviral Agents (Antivirals)IBA 01/2022 - 06/2003
21	Ribavirin (Virazole)FDA LinkGeneric 01/2021 - 06/2003
16	InterferonsIBA 01/2021 - 12/2003
9	SofosbuvirIBA 11/2019 - 01/2014
9	RNA (Ribonucleic Acid)IBA 11/2018 - 04/2006
8	Interferon-alpha (Interferon Alfa)IBA 01/2021 - 01/2006
6	Alanine Transaminase (SGPT)IBA 01/2022 - 12/2011
6	sofosbuvir drug combination ledipasvirIBA 01/2021 - 05/2014
6	SimeprevirIBA 05/2019 - 01/2017
5	Hepatitis B e AntigensIBA 12/2019 - 01/2006
5	Tenofovir (Viread)FDA Link 10/2019 - 12/2008
5	peginterferon alfa-2a (Pegasys)FDA Link 10/2015 - 11/2006
4	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 03/2012
4	NucleotidesIBA 01/2017 - 01/2010
3	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 03/2021 - 03/2016
3	paritaprevirIBA 11/2019 - 01/2019
3	ombitasvirIBA 05/2019 - 01/2018
3	daclatasvirIBA 05/2019 - 01/2017
3	ledipasvirIBA 11/2018 - 05/2014
3	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 12/2008
3	peginterferon alfa-2b (Pegintron)FDA Link 06/2013 - 09/2011
3	NucleosidesIBA 03/2012 - 01/2006
3	Amantadine (Aman)FDA LinkGeneric 11/2008 - 06/2003
2	CytokinesIBA 01/2021 - 10/2011
2	Ritonavir (Norvir)FDA Link 11/2019 - 02/2017
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2017
2	velpatasvirIBA 01/2019 - 01/2017
2	adefovirIBA 03/2012 - 09/2006
2	CholesterolIBA 12/2011 - 05/2008
2	adefovir dipivoxil (Hepsera)FDA Link 01/2011 - 12/2008
1	EnzymesIBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2020
1	Ferritins (Ferritin)IBA 12/2020
1	Fetal Proteins (Fetoprotein)IBA 09/2020
1	elbasvirIBA 07/2020
1	grazoprevirIBA 07/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Aspartic Acid (Aspartate)FDA Link 12/2019
1	Cytochrome P-450 CYP2B1 (PROD)IBA 05/2019
1	dasabuvirIBA 05/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	odalasvirIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2019
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 10/2017
1	Interferon LambdaIBA 10/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2017
1	seladelparIBA 10/2017
1	RHO(D) antibody (anti-D)IBA 10/2017
1	27- cyclohexyl- 12,13,16,17- tetrahydro- 22- methoxy- 11,17- dimethyl- 10,10- dioxide- 2,19- methano- 3,7:4,1- dimetheno- 1H,11H- 14,10,2,9,11,17- benzoxathiatetraazacyclo docosine-8,18(9H,15H)-dioneIBA 02/2017
1	GSK2336805IBA 02/2017
1	voxilaprevirIBA 01/2017
1	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 01/2017
1	Transaminases (Aminotransferases)IBA 03/2016
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 02/2016
1	BilirubinIBA 02/2016
1	danoprevirIBA 10/2013
1	Sorafenib (BAY 43-9006)FDA Link 01/2013

Therapy/Procedure

36	Therapeutics 01/2022 - 06/2003
4	Opiate Substitution Treatment 07/2022 - 01/2018
3	Duration of Therapy 01/2014 - 04/2006
2	Aftercare (After-Treatment) 01/2018 - 08/2007
1	Retreatment 01/2021
1	Treatment Delay 06/2013